🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The main aim of this study is to learn how safe elritercept is and how well...
Status
Recruiting
Location
Genesis Cancer and Blood Institute
Start Date
2020-08-19
Trial ID
NCT04419649
Treatments Being Tested
This study aims to explore the feasibility, safety, and preliminary efficac...
Status
Recruiting
Location
Department of Hematology, Guangdong Second Provincial General Hospital
Start Date
2026-06-01
Trial ID
NCT07663864
Treatments Being Tested
This is a prospective multicenter phase II basket trial evaluating Luspater...
Status
Not Yet Recruiting
Location
GCS Groupement des Hôpitaux de l'Institut Catholique de Lille
Start Date
2026-01-15
Trial ID
NCT07331818
Treatments Being Tested
Anemia in patients with very low, low or intermediate risk myelodysplastic ...
Status
Recruiting
Location
Praxis für Hämatologie und Onkologie Berlin-Mitte
Start Date
2022-09-27
Trial ID
NCT05384691
Treatments Being Tested
This MyeloMATCH Master Screening and Reassessment Protocol (MSRP) evaluates...
Status
Recruiting
Location
University of Alabama at Birmingham Cancer Center
Start Date
2024-06-18
Trial ID
NCT05564390
Treatments Being Tested
A Phase 3b, open-label, single-arm, rollover study to evaluate the long-ter...
Status
Recruiting
Location
Local Institution - 968
Start Date
2019-08-12
Trial ID
NCT04064060
Treatments Being Tested
This is a prospective, single-arm, open-label study. Twenty adult patients ...
Status
Unknown
Location
The second affiliated hospital of Sun Yat-sen University
Start Date
2022-07
Trial ID
NCT05462548
Treatments Being Tested